The Clinical Haematology team at NUH are looking for a new colleague to join their integrated forward thinking service.  This is an opportunity to join a nationally leading centre at the forefront of research and clinical innovation in haemato-oncology. This is a new substantive post within the Malignant Haematology team, reflecting the increasing academic commitments of the team and complexity of care. The successful candidate should have a demonstrable clinical and research interest in CLL or myeloma.

The successful candidate will work alongside the three current myeloma consultants and 2 CLL consultants, supported by myeloma fellow, CLL/lymphoma fellow, four clinical nurse specialists, and a large clinical research team. The candidate will have an opportunity to be centrally involved in active clinical research programs within CLL and myeloma.

This role offers opportunities to participate in undergraduate and postgraduate teaching, educational supervision, and research and leadership roles within the specialty. 

Nottingham University Hospitals NHS Trust is one of the largest in the UK with an annual turnover of approximately £1 billion. It was formed in 2006, when two top-rated trusts Queen’s Medical Centre and Nottingham City Hospital merged in order to develop a range of high-quality, sustainable patient services across the two campuses.  The Russell Centre for Clinical Haematology at the City Campus is a purpose-built, four storey modern building housing two inpatient wards, day case and outpatient clinic facilities, including an apheresis suite.

The Department is one of the largest centres for the treatment of haematological malignancies in the UK with a strong reputation for clinical trials and clinical research. This is an ideal opportunity for an ambitious and confident doctor keen to further develop clinical, research and leadership skills in a dynamic inclusive team.

The appointee will be expected to fulfil the following duties within the agreed Job Plan. The post-holders will join a team of 11 other Consultants offering a full haematological malignancy service and will have a special interest in CLL and/or Myeloma. The appointee will join in the attending rota with Dr Martinez-Calle (CLL) and Drs Frances Wadelin, Dean Smith and Kandeepan Saravanamuttu (Myeloma). The appointee  and will provide weekly acute (haemato)-oncology (AOS) service cover on the specialist receiving ward unit and provide advice to primary care through the GP advice and guidance service. The appointee will actively contribute to the weekly CLL and Myeloma MDTs.